中文

Delivering the impact of solid-state properties in pharmaceutical development

Organic Synthesis

Crystal Pharmatech’s Advantage:

        Insights Gained Through Solid State and Analytical Studies


Leveraging solid state expertise to maximize crystallization and isolation operations:

  • Optimum placement of final product isolation in the route
  • Polymorph and particle size control of API and intermediates
  • Strategies for efficient intermediate isolation and telescoping of steps

Leveraging analytical expertise to give efficient processes:

  • Identification and monitoring of byproducts to ensure clean reactions
  • Identification of stability liabilities and implementation of mitigation strategies

Design of practical and economical synthetic routes:

  • Organic chemistry expertise to give best reaction choice
  • Industry experience to guarantee proper solvent & reagent choice for environmentally acceptable processes


Kevin Wang, Ph.D.

VP, Department Head

Founder, CEO of ACS Scientific, Inc

(CRO in USA) - 10years

(placeholder)

  • 20 Journal publications, book chapter and patents
  • 20 Years of Organic Synthesis experience
  • 1,000 Various Projects (From 1 gram to 100kg Custom Synthesis, Bundling Blocks, API Intermediates)